| Lightcalls.com |
|
|
![]() |
Over the last not many years, the I...Over the last not many years, the ICABC has been actively encouraging the provincial management to balance its budget and make known a debt management plan. We were pleased when the control was able to balance its 2004/05 package and pay down the provincial sin by $1.9 billion in 2005 as a rise of a strong budget surplus1-this reduc the province's taxpayer-supported debt-to-GDP ratio to 183% keeping BC's misdoing level below both Ontario and the national average. Still, we continue to call for shortcoming repayment because our neighbour to the east has no misdoing because we still spend $16 billion dollars a year in interest payments, and because investors want to descry our debt reduced to make secure stable tax rates. Taxpayer-supported debt-to-GDP ratio Over the last five years, BC has consistently maintained the lowest taxpayer-supported debt-to-GDP ratio of all the jurisdictions reviewed in the BC Check-Up report (with the exception of Alberta), and this ratio is brewed to decline further over the nearest three years. However, BC's debit did increase during the 1990 at a time when other provincial guidances saw their fiscal positions improve and their debit burdens decline accordingly. On average, provincial controls reduced their debt-service burdens (interest paid) from about 145 cent upon every revenue dollar in the mid-1990s, to approximately 10 cent today.2 Several provinces were also able to introduce tax chops while increasing spending on health care, education, and infrastructure.3 Unfortunately, this was not the case in BC where the taxpayer-supported debt-to-GDP ratio increased steadily during the 1990 In 1984/85 taxpayer-support shortcoming in the province was just 13% of GDP yet by 1998/99 it had passed 20% reaching its peak of 213% in 2002/03 generally British Columbians pay $1.6 billion in interest each year in succession our taxpayer-supported debt. Debt reduction and repayment are not just an important means of improving competitiveness-they're also important because interest cash takes resources away from programs and services for British Columbians. Current debt-repayment initiatives EC's roll surplus of $2.6 billion in 2004 is the terminate of several positive developments during the past three years: stout economic growth, prudent fiscal management, and larger federal dominion transfers. The government's ability to qualified its annual budget targets and maintain a soft taxpayer-supported debt-to-GDP ratio have earned BC an upgraded credit rating from the three major credit rating agencies throughout the past year.4 This reward surplus also enabled the provincial management to increase spending on priority programs similar as health care and education, and stretch out tax relief in a variety of forms. further the projected surpluses for the nearest two years are expected to fall to $220 million and $200 million respectively,5 and no firm commitments have been made with regard to hereafter debt repayment. Looking forward In 1995 the then-NDP guidance developed and committed to a debt-management plan that called for a taxpayer-supported debt-to GDP ratio of 102% by dint of 201 5; unfortunately, this plan was cancelled just single in kind year later. Nonetheless, this target remains reasonable. The ICABC attract favor tos that the BC government commit to automatically applying any unused portion of the contingency capitals to the debt, and commit to a targeted taxpayer-supported debt-to-GDP ratio of les than 10% within the nearest decade. We also recommend a long-term debt-management plan that stakes targets for debt reduction throughout a ten-year period. Predictions give an inkling of that over the next five years, BC will experience GDP vegetation that is ahead of the national average. We believe the province must take advantage of this produce period to begin paying down the transgression and that the government should commit to a long-term debt-management plan now, while interest rates are depressed our debt-to-GDP ratio is heading downwards, and we're in a surplus position. A plan that manages and forms the debt, particularly as a portion of the GDP will enable the conduct to reallocate to other priorities more [i]or[/i] less of the $1.6 billion commonly spent each year to pay fault interest and debt servicing. It will also give the command greater flexibility to deal with challenges like rising health-care preciousnesss social demands, and the inevitable up and downs of EC's resource-based economy. More forward the budget next month More information forward the ICABC's 2006/07 budget submission and recommendations to the pick out Standing Committee on Finance and regulation Services will be provided in nearest month's GR Update. Endnotes 1 direction of British Columbia. Ministry of Finance recents release: June 29, 2005. "Public Accounts Confirm Record Surplus, due Reduction." 2 Jestin, Warren and Mary Webb. Scotiabank cluster Economic Directions (June 1 5 2005) "Federal-Provincial Fiscal Arrangements: Time to procure Back to Basics." 3 Ibid. 4 dominion of British Columbia. Ministry of Finance of the present days release: June 29, 2005. "Public Accounts Confirm Record Surplus, offence Reduction." |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |